Science Explorer Back to mapMap
Discussion
Researcher · Mie University · Japan

Hiroshi Shiku

Hiroshi Shiku publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Immunotherapy and Immune Responses, CAR-T cell therapy research and Immune Cell Function and Interaction.

ORCID 0000-0002-0362-755X OpenAlex
World rank
#1,852,600
of 7,710,434 ranked researchers
Rank in Japan
#32,460
of 383,136
Works
783
Citations
22k
Citations per work
28.1
h-index
74
i10-index 375Top 1.2% in Immunology
Hiroshi Shiku

What does Hiroshi Shiku research?

Hiroshi Shiku's work is mostly in Medicine (30%), Immunology and Microbiology (23%), Biochemistry, Genetics and Molecular Biology (16%).

Life Sciences: 306 works · 39.1% of their workImmunology and Microbiology: 181 works · 23.1% of their workImmunology: 181 works · 23.1% of their workBiochemistry, Genetics and Molecular Biology: 125 works · 16.0% of their workMolecular Biology: 125 works · 16.0% of their workEverything else: 240 works · 30.6% of their workHealth Sciences: 237 works · 30.3% of their workMedicine: 237 works · 30.3% of their workOncology: 99 works · 12.7% of their workHematology: 72 works · 9.2% of their workRadiology, Nuclear Medicine and Imaging: 36 works · 4.6% of their workPathology and Forensic Medicine: 30 works · 3.8% of their workTHEIR WORKHiroshi Shiku783works
Life Sciences39%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology18123.1%
    2. Biochemistry, Genetics and Molecular Biology12516.0%
  2. Everything else24030.6%
    1. Medicine23730.3%
  1. 1Immunology23% of their works
  2. 2Molecular Biology16% of their works
  3. 3Oncology13% of their works
  4. 4Hematology9% of their works
  5. 5Radiology, Nuclear Medicine and Imaging5% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Hiroshi Shiku's research?

The keywords of their largest research topics: Cancer Immunotherapy, Dendritic Cells, Immunity, Lymphoma, Glycosylation, CAR T Cells, Chimeric Antigen Receptor and Natural Killer Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Immunotherapy3072 topics
  2. Dendritic Cells1791 topic
  3. Immunity1791 topic
  4. Lymphoma1792 topics
  5. Glycosylation1362 topics
  6. CAR T Cells1281 topic
  7. Chimeric Antigen Receptor1281 topic
  8. NK Cell Recognition941 topic
  9. Natural Killer Cells941 topic
  10. Fc Receptors811 topic
  11. Therapeutic Antibodies811 topic
  12. Foxp3591 topic
  13. TGF-ß591 topic
  14. Cancer551 topic
  15. Glycans551 topic
  16. Protease-Activated Receptors551 topic
  17. Thrombin551 topic
  18. Classification511 topic
  19. Molecular Profiling511 topic

Where does Hiroshi Shiku work?

Hiroshi Shiku's main affiliation in the publication record is Mie University, Japan.

How many publications and citations does Hiroshi Shiku have?

OpenAlex counts 783 works and 22,008 citations for Hiroshi Shiku, an h-index of 74, ranking #1,852,600 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hiroshi Shiku. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.